Pterostilbene's two methyl groups (vs resveratrol's hydroxyl groups) make it more lipophilic, dramatically improving absorption and half-life. It activates SIRT1 (longevity pathway), PPAR-α (lipid metabolism), and AMPK (metabolic sensor), while inhibiting NF-κB (inflammation). For blood pressure, it increases NO bioavailability and reduces vascular oxidative stress. The LDL increase mechanism is unclear — it may involve PPAR-α-mediated changes in lipoprotein metabolism. The 4x bioavailability advantage means you can achieve plasma levels with 100mg pterostilbene that would require 500mg+ resveratrol.
No critical interactions identified at standard doses.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.